Kinshasa Lung Ultrasound Approach Validation
Launched by UNIVERSITY OF OXFORD · Feb 17, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Kinshasa Lung Ultrasound Approach Validation trial is studying a new method called the Kinshasa lung ultrasound (K-LUS) to help diagnose respiratory diseases in children aged 3 months to 14 years who are admitted to hospitals in the Democratic Republic of Congo and Bangladesh. This approach combines guidelines from the World Health Organization with special techniques for using ultrasound on children’s lungs. In this study, doctors will first make a diagnosis based on their assessment, and then a trained research assistant will perform a lung ultrasound to see if it matches the doctor’s diagnosis. After the children leave the hospital, a panel of experts will review all the information to confirm the most likely diagnosis.
To participate in this study, children must be between 3 months and 14 years old and have been admitted to the hospital with symptoms like cough or trouble breathing. However, children who are expected to stay in the emergency department for less than 6 hours, those transferred to another facility, or those whose parents do not give permission to participate will not be included. This trial is currently recruiting participants and aims to improve the way respiratory conditions are diagnosed in young patients, which could lead to better treatment outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged between 3 months and 14 years;
- • Admitted to the emergency department or ward with cough or difficulty in breathing;
- Exclusion Criteria:
- • Expected short stay in the emergency department (\< 6h)
- • Emergency transfer to other facilities
- • Refusal of informed consent by attending parent or caregiver, as appropriate
- • Lung ultrasound not feasible (e.g. non-availability of a trained physician)
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chittagong, , Bangladesh
Kinshasa, , Congo, The Democratic Republic Of The
Pujehun, , Sierra Leone
Patients applied
Trial Officials
Luigi Pisani
Principal Investigator
Mahidol Oxford Tropical Medicine Research Unit Faculty of Tropical Medicine, Mahidol University Thailand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported